BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Reversal of Atopic Dermatitis with Narrow-Band UVB Phototherapy and Biomarkers for Therapeutic Response

Dataset: Reversal of Atopic Dermatitis with Narrow-Band UVB Phototherapy and Biomarkers for Therapeutic Response

Background: Atopic dermatitis (AD) is a common inflammatory skin disease exhibiting a predominantly Th2/“T22” immune activation and a...

Registered by ArrayExpress Uploader
View Dataset

Background: Atopic dermatitis (AD) is a common inflammatory skin disease exhibiting a predominantly Th2/“T22” immune activation and a defective epidermal barrier. Narrow-band UVB (NB-UVB) is considered an efficient treatment for moderate to severe AD. In psoriasis, NB-UVB has been found to suppress the Th1/Th17 immune polarization with subsequent reversal of epidermal hyperplasia. The immunomodulatory effects of this treatment are largely unknown in AD. Our study evaluates the effects of NB-UVB on immune and barrier abnormalities in AD, aiming to establish reversibility of disease and biomarkers of therapeutic response. Methods: 12 moderate-to-severe chronic AD patients received NB-UVB phototherapy 3 times weekly for up to 12 weeks. Lesional and non-lesional skin biopsies were obtained before and after treatment and evaluated by gene-expression and immunohistochemistry studies. Results: All patients had at least a 50% reduction in SCORing of AD (SCORAD) index with NB-UVB phototherapy. The Th2, T22, and Th1 immune pathways were suppressed and measures of epidermal hyperplasia and differentiation also normalized after phototherapy. The reversal of disease activity was associated with elimination of inflammatory leukocytes, Th2/“T22”-associated cytokines and chemokines, and normalized expression of barrier proteins. Conclusions: Our study shows reversal of both the epidermal defects and underlying immune activation in AD. By determining the correlation of variables with therapeutic response, we have defined a set of biomarkers of disease response that associate resolved Th2 and T22 inflammation with reversal of barrier pathology. This data supports the “inside-out” hypothesis of AD, suggesting that it is a disease primarily driven by an immune stimulus. genomic profiling of treatment effect of NB-UVB in AD in both lesional and non-lesional AD skin from 10 patients. Treatment effect , disease state analysis

Species:
human

Samples:
35

Source:
E-GEOD-27887

Updated:
Dec.12, 2014

Registered:
Sep.15, 2014


Factors: (via ArrayExpress)
Sample PATIENT TISSUE SCORAD TIME
GSM688738 P7 non-lesional skin 0 post-treatment
GSM688739 P7 lesional skin 0 post-treatment
GSM688740 P1 non-lesional skin 0 post-treatment
GSM68874 P1 lesional skin 0 post-treatment
GSM688742 P10 non-lesional skin 0 post-treatment
GSM688743 P10 lesional skin 0 post-treatment
GSM688744 P2 non-lesional skin 0 post-treatment
GSM688745 P2 lesional skin 0 post-treatment
GSM688746 P4 non-lesional skin 0 post-treatment
GSM688747 P4 lesional skin 0 post-treatment
GSM688748 P6 non-lesional skin 0 post-treatment
GSM688749 P6 lesional skin 0 post-treatment
GSM688750 P5 non-lesional skin 0 post-treatment
GSM68875 P5 lesional skin 0 post-treatment
GSM688752 P8 non-lesional skin 0 post-treatment
GSM688753 P8 lesional skin 0 post-treatment
GSM688754 P3 non-lesional skin 0 post-treatment
GSM688755 P3 lesional skin 0 post-treatment
GSM688756 P7 non-lesional skin 0 pre-treatment
GSM688757 P7 lesional skin 55 pre-treatment
GSM688758 P9 non-lesional skin 0 pre-treatment
GSM688759 P9 lesional skin 76 pre-treatment
GSM688760 P1 non-lesional skin 0 pre-treatment
GSM68876 P1 lesional skin 37 pre-treatment
GSM688762 P10 non-lesional skin 0 pre-treatment
GSM688763 P10 lesional skin 70 pre-treatment
GSM688764 P2 non-lesional skin 0 pre-treatment
GSM688765 P2 lesional skin 51 pre-treatment
GSM688766 P4 non-lesional skin 0 pre-treatment
GSM688767 P4 lesional skin 33 pre-treatment
GSM688768 P6 lesional skin 0 pre-treatment
GSM688769 P5 non-lesional skin 57 pre-treatment
GSM688770 P8 lesional skin 0 pre-treatment
GSM68877 P3 non-lesional skin 36 pre-treatment
GSM688772 P3 lesional skin 0 pre-treatment

Tags

  • atopic dermatitis
  • dermatitis
  • disease
  • psoriasis
  • skin
  • skin disease

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2023 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use